PNC Financial Services Group’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
PNC Financial Services Group's PRAX Position: Q3 2026 in Review
PNC Financial Services Group increased its Praxis Precision Medicines (PRAX) stake by 16% in Q3 2026, buying an estimated $86.4K and bringing the position to 1,854 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #1774.
PNC Financial Services Group first reported a position in PRAX in Q4 2024 and has held it in 8 quarters since. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- PNC Financial Services Group held 1,854 shares of Praxis Precision Medicines worth $540K as of Q3 2026.
- PNC Financial Services Group bought 261 Praxis Precision Medicines shares in Q3 2026, an estimated $86.4K.
- Praxis Precision Medicines made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1774 holding.
- PNC Financial Services Group first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 8 quarters since.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.